News

Video

How Biomarker Testing Can Shape a Breast Cancer Treatment Plan

Author(s):

Fact checked by:

Biomarkers can shape a breast cancer treatment plan, Andy Guinigundo explained in an interview with CURE.

Guinigundo is a nurse practitioner and the director of precision oncology for Cincinnati Cancer Advisors. He sat down with CURE during the 42nd Annual Miami Breast Cancer Conference to discuss biomarkers and the role they can play during the treatment journey of a patient with breast cancer.

“It definitely can change your treatment plan,” said Guinigundo. “With these estrogen receptors, progesterone receptors, HER2 that we've been checking for all these decades, it tells us whether or not you can take an anti-estrogen pill or should take an anti-estrogen pill at some point in your therapy, or it won't work.”

Transcript:

The line between traditional pathology and biomarker testing is becoming increasingly blurry. The traditional biomarkers that we've been looking at for decades now—estrogen receptors, progesterone receptors (sometimes abbreviated as ER, PR), and HER2—we've been checking those for two decades or longer. However, some of these newer biomarkers are a bit different. Within today's science, we're looking a lot at genetic markers—so, whether it's something we inherited from our parents, or something the tumor has that's unique to itself, different from every other cell in your body. In that sense, it differs from traditional pathology.

Yes, it can change your treatment plan. Like I said, with estrogen receptors, progesterone receptors, and HER2, which we've been checking for all these decades, it tells us whether you can or should take an anti-estrogen pill at some point in your therapy, or if it won't work. It tells us whether you should be taking a drug like Herceptin (trastuzumab), which is an anti-HER2 drug. But yes, some of these newer biomarkers are very specific: you have a target, you have a drug. If you don't have that target, you can't use that drug.

Transcript has been edited for clarity and conciseness.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Daniel Jernazian, who beat cancer twice, credits his sports mindset for survival and calls it winning his ‘life World Championship’.
Patients in rural or underserved areas may have worse outcomes, highlighting the need for early support to address care access barriers.
Image of man with text.
Dr. Emre Yekedüz discusses how ASCO 2025 highlights precision medicine, biomarkers and the gut microbiome as keys to advancing kidney cancer care.
Dr. Breelyn Wilky stresses the importance of expert guidance and second opinions for patients with GIST, as treatment options continue to evolve rapidly.
Mark Daniels, 83, credits CAR T-cell therapy and compassionate care for helping him overcome lymphoma and endure the isolating treatment toll.
An early study of BGB-16673 for hard-to-treat leukemia found that side effects were manageable with no new safety concerns.
Image of woman with text.
Image of goy, and text.
Watch oncology dietitian Kenisha Parikh prepare creamy lentil soup, a soothing, protein-packed recipe to help ease side effects during treatment.